98 results about "Right femoral vein" patented technology

Disclosed is a valve implanting device comprising a collapsible frame, inner and outer guide wires removably connected to the collapsible frame, and a plurality of valve flaps attached to the collapsible frame. The collapsible frame is inserted into a patient's femoral vein or artery, guided to a deployment position using the guide wires, expanded using the guide wires, and stabilized using the guide wires to manipulate fixating hubs on the collapsible frame. The collapsible frame includes a central hub, a plurality of spokes, fixating hubs, gripping members, and a plurality of valve flaps.

An apparatus and methods for the prevention or minimization of lower extremity venous thrombosis comprising an impedance component disposed at the proximal end of the lower extremity and a compression component disposed at the distal end of the lower extremity. The proximal impedance component is activated to impede return venous blood flow, preferably on the femoral vein, until blood volume in the lower extremity is maximized. In response to deactivation of the proximal compression component, the distal compression component is activated to assist return venous blood flow. The apparatus and methods enhance blood circulation in the lower extremity by increasing washout of stagnant blood from the lower extremity, particularly from the venous sinuses and valve cusps where thrombosis tends to form.

An intravascular filter configured for upstream or downstream retrieval and a method for retrieving an intravascular filter from a patient's vena cava through the patient's femoral vein. The filter includes a downstream hub, an upstream hub, a plurality of primary struts extending from the downstream hub to the upstream hub, a plurality of secondary struts extending upstream from fixed ends housed in the downstream hub to free ends, secondary strut eyelets disposed at the free ends of the secondary struts, a loop member disposed through the secondary strut eyelets, an upstream coupling element disposed with the upstream hub, and a tether extending from the loop member to the upstream coupling element.

The invention provides a locally-plugged thrombus scaler, which comprises a core tube, a sleeve, a first saccule, a second saccule and a thrombus scraping skein, wherein the sleeve is sleeved outside the core tube in a movable way; the first saccule is connected to the head end of the core tube; the second saccule is sleeved outside an inner tube of the sleeve; and the thrombus scraping skein is sleeved outside the core tube in a movable way and is arranged in front of the sleeve. By the locally-plugged thrombus scaler, two saccules are expanded simultaneously to plug thrombus deposition positions on veins and form a section of closed space, and thrombus is crushed and scraped by rotating the thrombus scraping skein in the closed space. The locally-plugged thrombus scaler can scrape thrombus completely, prevent vein inner membranes from being injured, discharge the thrombus from human bodies completely and prevent crushed small thrombus blocks from remaining in the human bodies, is suitable for scraping venous thrombosis of limbs of the human bodies and is particularly suitable for scraping the thrombus at the deep positions of femoral veins of the human bodies by using a percutaneous microtrauma surgical technology.

The invention encompasses methods for selectively enriching in rare particles from blood samples harvested from the vein jugular vein the femoral vein, the subclavian vein, or an artery. These rare particles can be circulating tumor cells, circulating stem cells, or fragments thereof. Blood samples harvested from different sources can contain higher or lower concentrations of rare particles. The rare particles can be enriched by applying the blood samples to a microfluidic device with a two dimensional array of obstacles.

Systems and methods for delivering a miniaturized blood pump configured to draw partially desaturated blood via the femoral vein from the inferior or superior vena cava. A cannula connected to the pump exits the femoral vein and is connected to the femoral artery with a cannula or vascular graft. The pump receives power from a percutaneous lead which runs parallel to the flexible cannula and then exits via a percutaneous opening in the skin. The pump in the venous system removes venous blood and pumps it into the femoral artery. In so doing pressure in the aorta is increased and back pressure in the venous system is decreased.

An intra pelvic cancer therapeutic agent perfusion apparatus and method for administering a cancer therapeutic agent to and recovering same from a cancer tissue site within the pelvis. The tip of a first sheath is percutaneously inserted into the femoral artery and the tip of a second sheath is inserted into the femoral vein. A first balloon catheter is inserted into the aorta through the femoral artery and a second balloon catheter is inserted into the vena cava through the femoral vein. The first balloon catheter is used to block the blood flow and the second balloon is inflated to form an intravenous closed region between the site of insertion in the vena cava and a lower limb side venous site. A body fluid containing a cancer therapeutic agent is administered to the intra arterial closed region through the first sheath and is removed therefrom through the second sheath.

A set (FIG. 1&2) designed to provide a durable access to the portal vein and to divert portal blood to the systemic circulation in order to relieve congested portal system. The set is composed of a duct (1) and a shunt tube (7). The duct is composed of a covered flexible tubular braid with two opened ends. One end has flaring edges and forms the inner opening (2) while the other end is sealed to form a hub (3). To insert the duct into the intrahepatic portal vein through the percutaneous route the duct is mounted over a puncture needle (13) and contained in a small-constrained diameter by means of a peel-away sheath (16). After the position of the inner opening of the duct has been adjusted to the desired location the said sheath is peeled away to allow the duct to expand. The shunt tube (7) is composed of a long flexible vascular graft (8) equipped at its upper end with a head (9) while its lower end is free to be sutured with the femoral vein (21). The said head is cupped at the inner side (10) to fit in the hub (3) of the said duct (1), while back of the said head has a window covered with an elastic membrane (11). This shunt tube is applied in case both a portal access and a porto-systemic shunt are required. In case of only a durable portal access is needed, a plug (4) with a central window covered by an elastic membrane (6) is applied to the hub of the duct. This prevents bleeding from the duct and simultaneously allows entrance of needles, catheters, etc. to the duct and portal vein.

A removable intravascular filter having a filtering configuration for capturing thrombi in a blood vessel and a retrieval configuration for removal from the blood vessel. The filter may be implanted in a patient's vena cava and may be removed from the vena cava through the patient's jugular or femoral vein. A method of removing an intravascular filter from a patient's vena cava through the patient's femoral vein is also provided.

The invention relates to an intravascular mild hypothermia therapy device which comprises a normal saline storage box, a first pipeline, an electronic refrigerator, a second pipeline, a central venous catheter and a third pipeline. The normal saline storage box and the electronic refrigerator are communicated through the first pipeline. The electronic refrigerator and the central venous catheter are communicated through the second pipeline. The central venous catheter and the normal saline storage box are communicated through the third pipeline. A pushing pump is arranged on the second pipeline. The liquid inlet end of a honeycomb meshed heat exchange pipe inside the electronic refrigerator is communicated with the first pipeline, and the liquid outlet end of the honeycomb meshed heat exchange pipe is communicated with the second pipeline. Normal saline inside the normal saline storage box is conveyed by the pushing pump into the honeycomb meshed heat exchange pipe and then cooled by an electronic refrigeration sheet into low-temperature normal saline, one end of the central venous catheter enters a lower plenum central vein from a human body femoral vein puncture opening, a temperature difference between the circularly-flowing normal saline and blood inside the central venous blood vessel, and heat exchange between the surface of the central venous blood vessel and the blood in the patient blood vessel is performed.

The invention discloses a two-way controllable releasable vena cava filter. The filter comprises a filtering part and a supporting part, the filtering part is of a grid structure which is formed in the mode that a plurality of supporting rods are cross-linked with each other, and the supporting part comprises a first supporting part and a second supporting part which are arranged on two sides of the filtering part, wherein the opening of the first supporting part is opposite to that of the second supporting part; the first supporting part gradually extends from the center to the outside in the forward direction and gradually overturns and curls in the reverse direction; the second supporting part gradually extends from the center to the outside in the forward direction. According to the two-way controllable releasable vena cava filter, implantation and recycling of the filter can be conducted through the femoral vein and the jugular vein, the thrombus filtering effect is good, the filter can be recycled after being implanted for a long time, and the filter can be more easily captured and recycled.

The invention discloses an ectopic implantation valved stent system for treating tricuspid regurgitation. The system comprises a stent, an artificial valve and a cover membrane, wherein the stent is in the shape of a cylindrical tube and provided with a grid structure, the artificial valve is sewn in the stent perpendicular to the axial direction of the stent, and the cover membrane covers at least part of the peripheral surface of the stent. The system is a valve system implanted through femoral vein. After the system is implanted in precava and/or postcava, the situation that tricuspid valve regurgitates into atrium, and then blood flows back to vena cava can be avoided, and then tricuspid regurgitation is treated. The stent system has the advantages that operation is easy, manufacturing process is simple and mature, and safety performance is high.

The device (1) is intended to be positioned in a sealed introducer placed in a femoral vein in order to penetrate the left atrium (4) of the heart (3) by passing through the septal wall (5) thereof. The device comprises an assembly for cooperating with a handle under the control of control means for actuation of the assembly, for placing and fixing a reinforcement ring (7) on the mitral valve (2), said assembly being arranged at the end of a manipulation rod (6) and comprising: a bearing member (8) comprising a plurality of arms (8a) connected pivotably to the end of the rod (6) so as to change, under the action of the control means, from a position folded along the rod (6) to a deployed position spaced apart from the rod (6), in order to bear under the mitral valve (2) in a manner uniformly distributed along the periphery of the mitral valve; a counter-bearing member (12) comprising a plurality of arms (12a), at the free end of which arms (12a) the reinforcement ring (7) is arranged, the arms (12a) are connected pivotably to a support (13) disposed coaxially with respect to the rod (6) in such a way as to change, under the action of the control means, from a position folded along the rod (6) to a deployed position spaced apart from the rod (6), in order to realize the counter-bearing on the mitral valve and to position the reinforcement ring (7); means for removing sutures for fixing the reinforcement ring (7) to the mitral valve.

The invention relates to a valve clip and a clipping system thereof. The valve clip can be used for effectively treating MR (Mitral Regurgitation) and TR (Tricuspid Regurgitation) after being implanted into the human body by the clipping system. By using the valve clip, the axial operating space of the valve clip can be shortened, and the operating direction can be changed, so that the capturing and clamping operation can be performed from the other side of the valve (i.e., the atrium side) so as to reduce the injury damage on the atrium and the chordae tendineae in the surgical operation process; the length of the valve clip can be shortened, so that the implanted valve clip is shorter so as to reduce the space of the ventricle side occupied by the valve clip, reduce the injury capable ofbeing caused by the valve clip on the heart tissue, and reduce the thrombus forming risk; in addition, after the clipping system passes through the femoral vein and punctures the septum of the rightatrium and the left atrium, the right atrium and the left atrium are used as a delivery path of the clip; the intercostal incision and cardiac apex puncture are not needed; and the surgical trauma issmaller.

The invention provides a valve stent, which comprises a stent main body arranged in a grid shape, at least a grabbing lug connected with the stent main body and a flange connected with the stent mainbody. According to the invention, the outer diameter D of the flange is larger than the diameter d of the connecting position of the flange and the stent main body, so that the lower horizontal planeof the flange is tightly attached to a heart native valve ring and valve leaflets, the edge upwarping end surface is tightly attached to the inner wall of left atrium, the upper limiting and sealing effects are achieved, and the valve stent is prevented from sliding out towards the left ventricle end; when the valve stent is compressed into a sheath, the grabbing lug is embedded into the stent main body grids connected with the grabbing lugs, so that the stent thickness of the valve stent after being pressed, held and reduced is reduced, and the valve stent can intervene into a human body through a femoral vein path so as to reduce the diameter of a conveyor catheter and reduce the conveying difficulty and the damage to blood vessels; and the grabbing lug simultaneously grabs native valveleaflet and hooks chordae tendineae to form lower limiting, so that the valve stent is prevented from being disengaged towards the left atrium end due to external force such as blood flow scouring, heart extrusion and the like.

An intravascular filter configured for retrieval through a patient's femoral vein and a method for retrieving the filter through the patient's femoral vein. The filter includes a plurality of struts having connected ends attached together along a longitudinal axis, a shaft disposed along the longitudinal axis and having a first end disposed with the connected ends of the struts, a first cuff slidably disposed on the shaft, and a second cuff disposed over the struts and connected to the first cuff.

The invention relates to a mitral valve replacement system for a percutaneous transcatheter, and belongs to the technical field of medical instruments. The mitral valve replacement system comprises avalve frame supporting body, an artificial valve leaflet and a ventricular septum anchoring structure. The valve frame supporting body is arranged between an atrium and a ventricle and provided with ahollow cavity with the two ends open. The artificial valve leaflet is arranged on the inner wall of the cavity of the valve frame supporting body. The ventricular septum anchoring structure is arranged between the valve frame supporting body and a ventricular septum. The invention provides the mitral valve replacement device intervened through a catheter via a femoral vein admission passage and aims to solve the problems that an existing interventional mitral valve system is generally large in valve stent, has the left ventricular outflow passage obstruction risk, has potential complicationsin transapical admission passage and anchoring and the like, and the mitral valve replacement device provided by the invention is more minimally invasive and firmer in anchoring, and the technical scheme of mitral valve replacement suffering from left ventricular outflow tract obstruction can be effectively avoided.